Natalie Cook

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (19)

Alicia-Marie Conway

The University of Manchester

UNITED KINGDOM

View details

Darren Ashcroft

The University of Manchester

UNITED KINGDOM

View details

Victoria Palin

The University of Manchester

UNITED KINGDOM

View details

Syed Hussain

Professor of Medical Oncology

University of Sheffield Medical School

UNITED KINGDOM

View details

Fiona Blackhall

The University of Manchester

UNITED KINGDOM

View details

Ana Arance

University of Barcelona

SPAIN

View details

Louise Carter

Clinical Senior Lecturer

The University of Manchester

UNITED KINGDOM

View details

Silvia Riva

Associate Professor

St Mary's University

UNITED KINGDOM

View details

William Welfare

Honorary Senior Clinical Lecturer

The University of Manchester

UNITED KINGDOM

View details

Nicola Flaum

The University of Manchester

UNITED KINGDOM

View details

Jorge Barriuso

The University of Manchester

UNITED KINGDOM

View details

Min-sun song

Assistant Research Professor

City of Hope

UNITED STATES

View details

Alastair Kerr

Head of Bioinformatics and Biostatistics

Cancer Research UK Manchester Institute

UNITED KINGDOM

View details

Eleni Domzaridou

The University of Manchester

UNITED KINGDOM

View details

Marek Dynowski

Head of IT and Scientific Computing

Cancer Research UK Manchester Institute

UNITED KINGDOM

View details

S. Percy Ivy

Associate Chief

National Cancer Institute

UNITED STATES

View details

ANTHONY D WHETTON

The University of Manchester

UNITED KINGDOM

View details

Tjeerd van Staa

The University of Manchester

UNITED KINGDOM

View details

Ines Pires da Silva

Senior Lecturer

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Natalie Cook

Research Interests

Explore related searches

Contact this professor

Articles (24)

Cancer of unknown primary: the hunt for its elusive tissue-of-origin – is it time to call off the search?

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

A single centre experience of patients with Rare Cancers referred for Early Phase Clinical Trials

Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients

Accelerating the Future of Oncology Drug Development

Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer

A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary

Is early-onset colorectal cancer an evolving pandemic?

Social determinants of health inequalities in early phase clinical trials in Northern England

Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials

Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours

Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population

A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer

The Impact of Oral Antibiotics Prior to Cancer Diagnosis on Overall Patient Survival: Findings from an English Population-Based Cohort Study

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study

Circulating tumour DNA — looking beyond the blood

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

Epic

Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small-cell lung cancer

Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small cell lung cancer.

Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials

A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

Collaborators (19)

Alicia-Marie Conway

Darren Ashcroft

Victoria Palin

Syed Hussain

Fiona Blackhall

Ana Arance

Louise Carter

Silvia Riva

William Welfare

Nicola Flaum

Jorge Barriuso

Min-sun song

Alastair Kerr

Eleni Domzaridou

Marek Dynowski

S. Percy Ivy

ANTHONY D WHETTON

Tjeerd van Staa

Ines Pires da Silva

Make your next move.